Ixabepilone in Treating Patients With Recurrent or Persistent Leiomyosarcoma of the Uterus Previously Treated With Chemotherapy

Conditions:   Recurrent Uterine Sarcoma;   Uterine LeiomyosarcomaInterventions:   Other: diagnostic laboratory biomarker analysis;   Drug: ixabepiloneSponsor:   National Cancer Institute (NCI)Active, not recruiting - verified June 2014
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials